Literature DB >> 11359826

Dissociation of Pax-5 from KI and KII sites during kappa-chain gene rearrangement correlates with its association with the underphosphorylated form of retinoblastoma.

H Sato1, D Wang, A Kudo.   

Abstract

The KI and KII sites play a crucial role in kappa-chain gene rearrangement, which was investigated in mice deficient for these sites. Previously, we found that Pax-5 can bind to the KI and KII sites; however, the function of Pax-5 in kappa-chain gene rearrangement has not been investigated. Here, we have used an in vitro culture system in which differentiation from pre-B cells to immature B cells is induced by removing IL-7. We showed that, after the induction of differentiation, Pax-5 dissociated from the KI and KII revealed by EMSA analyses, and this dissociation occurred specifically at the KI and KII sites, but not at the Pax-5 binding site, in the CD19 promoter because of a lower binding affinity of Pax-5 for the KI and KII sites. During differentiation induced by removing IL-7, the underphosphorylated form of retinoblastoma preferentially associated with Pax-5, which caused dissociation of Pax-5 from KI and KII sites. These results suggest that the dissociation of Pax-5 from the KI and KII sites is important in the induction of kappa-chain gene rearrangement.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359826     DOI: 10.4049/jimmunol.166.11.6704

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Patterns of gene divergence and VL promoter activity in immunoglobulin light chain clusters of the channel catfish.

Authors:  Julia Cay Jones; Seyed H Ghaffari; Craig J Lobb
Journal:  Immunogenetics       Date:  2004-09-03       Impact factor: 2.846

2.  Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA.

Authors:  Gabriella Livide; Maria Carmela Epistolato; Mariangela Amenduni; Vittoria Disciglio; Annabella Marozza; Maria Antonietta Mencarelli; Paolo Toti; Stefano Lazzi; Theodora Hadjistilianou; Sonia De Francesco; Alfonso D'Ambrosio; Alessandra Renieri; Francesca Ariani
Journal:  Pathol Oncol Res       Date:  2012-01-26       Impact factor: 3.201

3.  Enhancers as regulators of antigen receptor loci three-dimensional chromatin structure.

Authors:  E Mauricio Barajas-Mora; Ann J Feeney
Journal:  Transcription       Date:  2019-12-12

4.  Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray.

Authors:  Norihiko Kawamata; Seishi Ogawa; Martin Zimmermann; Birte Niebuhr; Carol Stocking; Masashi Sanada; Kari Hemminki; Go Yamatomo; Yasuhito Nannya; Rolf Koehler; Thomas Flohr; Carl W Miller; Jochen Harbott; Wolf-Dieter Ludwig; Martin Stanulla; Martin Schrappe; Claus R Bartram; H Phillip Koeffler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

5.  2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.

Authors:  Dina Schneider; Maria A Manzan; Robert B Crawford; Weimin Chen; Norbert E Kaminski
Journal:  J Pharmacol Exp Ther       Date:  2008-05-15       Impact factor: 4.030

6.  A novel pax5-binding regulatory element in the igκ locus.

Authors:  Rena Levin-Klein; Andrei Kirillov; Chaggai Rosenbluh; Howard Cedar; Yehudit Bergman
Journal:  Front Immunol       Date:  2014-05-23       Impact factor: 7.561

7.  The proximal J kappa germline-transcript promoter facilitates receptor editing through control of ordered recombination.

Authors:  Christian Vettermann; Greg A Timblin; Vivian Lim; Ernest C Lai; Mark S Schlissel
Journal:  PLoS One       Date:  2015-01-05       Impact factor: 3.240

Review 8.  Marking the tempo for myogenesis: Pax7 and the regulation of muscle stem cell fate decisions.

Authors:  Hugo C Olguín; Addolorata Pisconti
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

9.  The balance between Pax5 and Id2 activities is the key to AID gene expression.

Authors:  Hiroyuki Gonda; Manabu Sugai; Yukiko Nambu; Tomoya Katakai; Yasutoshi Agata; Kazuhiro J Mori; Yoshifumi Yokota; Akira Shimizu
Journal:  J Exp Med       Date:  2003-10-27       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.